MultiOmyx™: High-Order Multiplexing Methodology
NeoGenomics introduces MultiOmyx, a proprietary, multiplexing methodology that enables analysis of dozens of proteins and DNA biomarkers in a single tissue section. Instead of being able to study one or two disease markers at a time, MultiOmyx studies up to 60 biomarkers in a single tumor slice. It also uncovers the relationship between markers which could yield new insights and a more complete picture of tumor behavior.
The Key Benefits of MultiOmyx Include:
- Comprehensive biomarker profiling on a single FFPE slide – tissue samples are precious. MultiOmyx can evaluate up to 60 biomarkers in a single slide.
- Unambiguous Immune Cell Co-Expression and Co-localization
- Advanced Data Analysis
- Sample Requirements
|MultiOmyx™||Duplicate slides per sample, cut at thickness of 3-5 microns.||Transport of paraffin blocks and unstained slides are at room temperature. Please use positively-charged slides and 10% NBF fixative. Do not use zinc fixatives.|
Specimen requirements for tumor tissue: FFPE tissue: Paraffin block is preferred, slide preferences are listed above
Storage and Transportation: Use cold pack for transporting block and/or blood, making sure cold pack is not in direct contact with specimen. Peripheral Blood: Ship same day as drawn whenever possible; specimens <72 hours old.
NeoGenomics Laboratories, Inc.
Attn: Pharma Services
Aliso Viejo, CA92656
Phone: 949-445-7300 x7103
Customer Service: +1-888-248-5275
Latest MultiOmyx News
PD-1 and LAG-3 synergize to drive tumor-infiltration of T cytotoxic cells in NSCLC tumors
Presented at European Society For Medical Oncology (ESMO) Immuno-Oncology Congress
An Integrated Multiplexing Approach Identifies IDO1 as a Biomarker for Recurrence of Rare Ovarian Granulosa Cell Tumors
Presented at The Society for Immunotherapy of Cancer (SITC)
An Integrated Multiplexing Approach for the Immunoprofiling of the Tumor Microenvironment of Ovarian Granulosa Cell Tumors
Presented at European Organisation for Research and Treatment of Cancer